News

Clinical Study Seeks Participants with Lung Disease

Published Date:

Idiopathic pulmonary fibrosis (IPF) is a type of lung disease that results in scarring (fibrosis) of the lungs for an unknown reason. Over time, the scarring gets worse and it becomes harder to take deep breaths. The lungs become unable to take in enough oxygen.

Dr. Rajagopal Sreedhar is recruiting participants for a clinical trial to see if pulmonary rehabilitation treatments improve the quality of life for patients with IPF. The study will compare standard of care treatment to exercise and education. The goal is test how well the combination of exercise and medication benefits the patient. All study-related visits and tests will be provided at no cost to the participant. Participants may also receive a stipend to cover travel and other related expenses.

To qualify, participants must:

  • Be 40 years of age or older
  • Have been diagnosed with IPF
  • Be currently taking the medication Ofev® (150 mg twice a day) and have taken it at a stable dose for up to 30 months

To learn more about this study, contact Abigail House, RN, at 217-545-7526.

More from SIU News

Physician Assistant Challenge Bowl team

SIU PAs win Illinois Challenge Bowl

The SIU Physician Assistant Program’s Challenge Bowl team has won the Illinois Academy of Physician Assistants 2025 State Medical Challenge Bowl--their sixth in a row.
Skin cancer screening

SCI offering skin cancer screenings May 20

Central Illinois residents are encouraged to register for a free skin cancer screening from 5 - 7 p.m., Tuesday, May 20, at Simmons Cancer Institute at SIU Medicine, 315 W. Carpenter St. in Springfield.
ER simulation

SIU Medicine first in U.S. to pilot new trauma care course

SIU School of Medicine will host the first use of the newest edition of the Advanced Trauma Life Support course in the United States on April 29–30. The Southern Illinois Trauma Center (SITC) at Springfield Memorial Hospital and the Memorial Learning Center are piloting the training.